600079.SH
ST人福
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 17.85
−0.22%Margins
Gross margin
48.5%
EBITDA margin
17.6%
EBIT margin
13.7%
Net margin
8.0%
FCF margin
10.7%
9.8%
Return on equity
5.1%
Return on assets
11.7%
Return on invested capital
0.64x
Asset turnover
CNY 3.1B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026